SCHEMBL30988

SCHEMBL30988

CCOc1c(C)nn2c(N)ccnc12

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
TSHR P16473 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
GAA P10253 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
POLB P06746 1/20 0.34
KMT2A Q03164 1/20 0.34
LMNA P02545 1/20 0.34
NTRK1 P04629 5/20 0.33
PIM1 P11309 5/20 0.33
PLA2G2A P14555 1/20 0.33
GPR119 Q8TDV5 1/20 0.33
HPGD P15428 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30986 0.79 SMN1; SMN2 (0.36) MAPTNPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL1818321 0.75 NPC1 (0.44) MAPTNPC1RAB9ASMN1; SMN2KDM4E
Hydrochloric Acid SCHEMBL8156881 0.74 NPC1 (0.42) MAPTNPC1RAB9ASMN1; SMN2KDM4E
Hydrochloric Acid SCHEMBL461580 0.74 NPC1 (0.42) MAPTNPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL30579405 0.70 NPC1 (0.40) MAPTNPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL21061310 0.68 ALDH1A1 (0.39) MAPTNPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL7455962 0.67 NTRK1 (0.37) MAPTNPC1RAB9ASMN1; SMN2L3MBTL1
SCHEMBL25317207 0.67 NOS2 (0.42) MAPTNPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL7470373 0.67 PKM (0.46) MAPTNPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL10651514 0.65 NOS2 (0.55) MAPTSMN1; SMN2KDM4EALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2608668-A1 FUSED TRICYCLIC INHIBITORS OF MAMMALIAN TARGET OF RAPAMYCIN Merck Sharp & Dohme Corp. (US) 2013-07-03 EP disclosed
WO-2012027234-A1 FUSED TRICYCLIC INHIBITORS OF MAMMALIAN TARGET OF RAPAMYCIN SCHERING CORPORATION (US) 2012-03-01 WO disclosed